Ingenium Therapeutics

Next-gen cancer therapies powered by innate immunity.

founder

Jinok Koh

founded

2020

field

BIO∙Healthcare

"Laplace Partners provides invaluable guidance beyond investment, standing firmly with you through your toughest challenges."

"Laplace Partners provides invaluable guidance beyond investment, standing firmly with you through your toughest challenges."

"Laplace Partners provides invaluable guidance beyond investment, standing firmly with you through your toughest challenges."

Related Posts

CEO Interview: Jinok Ko of Ingenium Therapeutics

CEO Interview: Jinok Ko of Ingenium Therapeutics

CEO Interview: Jinok Ko of Ingenium Therapeutics

Subscribe

By subscribing, you agree to our Privacy Policy.

한국어

|

EN

© 2025 Laplace Partners

Subscribe

By subscribing, you agree to our Privacy Policy.

한국어

|

EN

© 2025 Laplace Partners

Subscribe

By subscribing, you agree to our Privacy Policy.

한국어

|

EN

© 2025 Laplace Partners